Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma-Reference-Cited by-同舟云学术

Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma

Published:2017-10-24 Issue:12 Volume:96 Page:2071-2078
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Zannetti Beatrice Anna,Tacchetti Paola,Pantani Lucia,Gamberi Barbara,Tosi Patrizia,Rocchi Serena,Cellini Claudia,Ronconi Sonia,Pezzi Annalisa,Mancuso Katia,Rizzello Ilaria,Caratozzolo Isola,Martello Marina,Dozza Luca,Cavo Michele^ORCID,Zamagni Elena

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3140-5/fulltext.html

Reference50 articles.

1. Kumar SK, Dispenzieri A, Lacy MQ et al (2014) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28:1122–1128

2. Attal M, Harousseau JL, Stoppa AM et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 335:91–97

3. Child JA, Morgan GJ, Davies FE et al (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348:1875–1883

4. Cavo M, Rajkumar SV, Palumbo A et al (2011) International myeloma working group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation. Blood 117:6063–6073

5. Engelhardt M, Terpos E, Kleber M et al (2014) European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica 99:232–242

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of second autologous stem‐cell transplantation at relapsed multiple myeloma: A French multicentric real‐life study;HemaSphere;2024-07-29

2. Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany;Bone Marrow Transplantation;2024-03-14

3. Post Salvage Therapy Autologous Transplant for Relapsed Myeloma, Ongoing Relevance within Modern Treatment Paradigms?;Clinical Lymphoma Myeloma and Leukemia;2023-02

4. The changing landscape of relapsed and/or refractory multiple myeloma (MM): fundamentals and controversies;Biomarker Research;2022-01-09

5. Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties;mAbs;2018-12-17